Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ) SHZ
2.92
+0(+0.00%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.73B |
| Enterprise Value | 6.43B |
| P/E Ratio | 15.29 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 3.01 |
| Price/Book Ratio | 2.63 |
| Enterprise/Revenue | 2.71 |
| Enterprise/EBITDA | 14.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.19 |
| Operating Margin | 0.21 |
Management Effectiveness
| Return On Assets | 0.13 |
| Return On Equity | 0.19 |
Income Statement
| Revenue | 2.14B |
| Revenue/Share | 0.97 |
| Gross Profit | 968.37M |
| EBITDA | 502.89M |
| Net Income | 376.91M |
| Diluted EPS | 0.17 |
Balance Sheet
| Total Cash | 947.73M |
| Total Cash/Share | 0.43 |
| Total Debt | 20.16M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 1.9 |
| Book Value Per Share | 1.1 |
Price History
| 52-Week Change | -1.03 |
| 52-Week High | 4.08 |
| 52-Week Low | 2.73 |
| Moving Average 50 Days | 3.42 |
| Moving Average 200 Days | 3.32 |
Statistics
| Average Volume | 100.62M |
| Shares Outstanding | 2.23B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 3:1 |
| Last Split Date | June 03, 2016 |
